Madrigal Pharmaceuticals, Inc.
Healthcare / Biotechnology
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Performance
--
Today 0.00 (0.00%)
MDGL
Metrics
Market Cap13B
Latest Price$530.54
Previous Close$529.09
Volume528K
52 Week High$615.00
52 Week Low$286.44
52 Week Change67.24%
Average Volume331K
Revenue1.1B
EPS-13.5
P/E Ratio0
Forward P/E44.708
Price/Book23.467
Profit Margin-0.27%
Operating Margin-0.30%
Return on Equity-0.49%
Dividend Yield0.00%